The AIM All Share had another down day, despite an uptick in sentiment both on the main board and across the Atlantic. The index has now lost around 30 points or 4% of its value over the last week, heading towards the close at 775.87, down seven on the day.
Thalia Therapeutics [LON:THAT] was topping the board with an hour to run. Trading up 17% on the day, the company announced a strategic acquisition this morning which propels it to a clinical stage company and is immediately value accretive. Significant director backing of an oversubscribed funding round has further cemented confidence.
Novacyt [LON:NCYT] was 15% higher, but there doesn’t seem to be anything behind the move. The stock has seen elevated levels of trading during the day but there’s nothing else to note.
TMT Investments [LON:TMT] has the notable mention, up 6% off a portfolio update. Whilst highlighting the benefits of a recent disposal, the note also laid bare the 60% discount to NAV that TMT trades at.
Proservice Building Marketplace [LON:PRO] was down 20%. There’s no news but the stock has been on this list a few times of late with questions being asked over the company’s funding position.
Velocity Composites [LON:VEL] was also down on the day, trading 13% lower heading into the close. This morning’s half year financial report highlighted “customer phasing and delayed programme transfers” which impacted revenues, margins and profits. This should be transitory and it’s worth adding that the move was across the quoted spread.
Get free weekly UK company analysis from The Armchair Trader here
‘ Este Articulo puede contener información publicada por terceros, algunos detalles de este articulo fueron extraídos de la siguiente fuente: sg.finance.yahoo.com ’
